
    
      Design, Settings, and Participants. A randomised, double-blind, placebo-controlled trial with
      MDD patients allocated to two treatment arms: citalopram + pindolol versus citalopram +
      placebo. Participants: outpatients with a depressive episode (DSM-IV criteria) were selected
      from a general hospital.
    
  